日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations

对RV144疫苗接种者在后期加强免疫后肛门生殖器分泌物中诱导的HIV-1 gp120抗体特异性进行表征

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0196397
Akapirat, Siriwat; Karnasuta, Chitraporn; Vasan, Sandhya; Rerks-Ngarm, Supachai; Pitisuttithum, Punnee; Madnote, Sirinan; Savadsuk, Hathairat; Rittiroongrad, Surawach; Puangkaew, Jiraporn; Phogat, Sanjay; Tartaglia, James; Sinangil, Faruk; de Souza, Mark S; Excler, Jean-Louis; Kim, Jerome H; Robb, Merlin L; Michael, Nelson L; Ngauy, Viseth; O'Connell, Robert J; Karasavvas, Nicos
HIV
免疫/内分泌
微生物学
发表日期：2018
文献求助 收藏

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

RV144、VAX003 和 VAX004 疫苗接种方案诱导的抗体反应比较

期刊:Aids Research and Human Retroviruses
影响因子:1.1
doi:10.1089/AID.2016.0204
Karnasuta, Chitraporn; Akapirat, Siriwat; Madnote, Sirinan; Savadsuk, Hathairat; Puangkaew, Jiraporn; Rittiroongrad, Surawach; Rerks-Ngarm, Supachai; Nitayaphan, Sorachai; Pitisuttithum, Punnee; Kaewkungwal, Jaranit; Tartaglia, James; Sinangil, Faruk; Francis, Donald P; Robb, Merlin L; de Souza, Mark S; Michael, Nelson L; Excler, Jean-Louis; Kim, Jerome H; O'Connell, Robert J; Karasavvas, Nicos
发表日期：2017
文献求助 收藏

Identification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E

在接种ALVAC-HIV和AIDSVAX B/E疫苗的个体中，鉴定与抗体结合位点共定位的免疫优势CD4限制性表位。

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0115582
Ratto-Kim, Silvia; de Souza, Mark S; Currier, Jeffrey R; Karasavvas, Nicos; Sidney, John; Rolland, Morgane; Valencia-Micolta, Anais; Madnote, Sirinan; Sette, Alessandro; Nitayaphan, Sorachai; Pitisuttuthum, Punnee; Kaewkungwal, Jaranit; Rerks-Ngarm, Supachai; O'Connell, Robert; Michael, Nelson; Robb, Merlin L; Marovich, Mary; Kim, Jerome H
T细胞
HIV
微生物学
CD4
免疫/内分泌
发表日期：2015
文献求助 收藏

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

在泰国开展的I/II期疫苗试验中，采用不同疫苗接种方案，对重组gp120蛋白、gp70V1/V2支架和环状V2肽的IgG抗体反应

期刊:Aids Research and Human Retroviruses
影响因子:1.1
doi:10.1089/AID.2015.0034
Karasavvas, Nicos; Karnasuta, Chitraporn; Savadsuk, Hathairat; Madnote, Sirinan; Inthawong, Dutsadee; Chantakulkij, Somsak; Rittiroongrad, Surawach; Nitayaphan, Sorachai; Pitisuttithum, Punnee; Thongcharoen, Prasert; Siriyanon, Vinai; Andrews, Charla A; Barnett, Susan W; Tartaglia, James; Sinangil, Faruk; Francis, Donald P; Robb, Merlin L; Michael, Nelson L; Ngauy, Viseth; de Souza, Mark S; Paris, Robert M; Excler, Jean-Louis; Kim, Jerome H; O'Connell, Robert J
IgG
发表日期：2015
文献求助 收藏

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120

泰国 III 期 HIV 1 型疫苗试验 (RV144) 方案诱导针对 gp120 V2 环内保守区域的抗体

期刊:Aids Research and Human Retroviruses
影响因子:1.5
doi:10.1089/aid.2012.0103
Nicos Karasavvas, Erik Billings, Mangala Rao, Constance Williams, Susan Zolla-Pazner, Robert T Bailer, Richard A Koup, Sirinan Madnote, Duangnapa Arworn, Xiaoying Shen, Georgia D Tomaras, Jeffrey R Currier, Mike Jiang, Craig Magaret, Charla Andrews, Raphael Gottardo, Peter Gilbert, Timothy J Cardozo
HIV
微生物学
发表日期：2012
文献求助 收藏